Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
BINDING AFFINITY;
BREAST CARCINOMA;
CANCER CELL CULTURE;
CELL STRAIN MCF 7;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
STRUCTURE ACTIVITY RELATION;
The status of platinum anticancer drugs in the clinic and in clinical trials
N.J. Wheate, S. Walker, G.E. Craig, and R. Oun The status of platinum anticancer drugs in the clinic and in clinical trials Dalton Trans. 39 2010 8113 8127
DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent
K. Stehlikova, H. Kostrhunova, J. Kasparkova, and V. Brabec DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent Nucleic Acids Res. 30 2002 2894 2898 (Pubitemid 34778149)
Solution structure of a cisplatin-induced DNA interstrand cross-link
H. Huang, L. Zhu, B.R. Reid, G.P. Drobny, and P.B. Hopkins Solution structure of a cisplatin-induced DNA interstrand cross-link Sciences 270 1995 1842 1845 (New York) (Pubitemid 26007235)
Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues
DOI 10.1021/bc0499331
O. Aronov, A.T. Horowitz, A. Gabizon, M.A. Fuertes, J.M. Perez, and D. Gibson Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues Bioconjug. Chem. 15 2004 814 823 (Pubitemid 38981956)
Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies
DOI 10.1021/bc025642l
O. Aronov, A.T. Horowitz, A. Gabizon, and D. Gibson Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies Bioconjug. Chem. 14 2003 563 574 (Pubitemid 36597366)
Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells
DOI 10.1016/j.canlet.2004.06.035, PII S0304383504004744
C. Lottner, R. Knuechel, G. Bernhardt, and H. Brunner Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells Cancer Lett. 215 2004 167 177 (Pubitemid 39370034)
Searching for the magic bullet: Anticancer platinum drugs which can be accumulated or activated in the tumor tissue
M. Galanski, and B.K. Keppler Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in the tumor tissue Anticancer Agents Med. Chem. 7 2007 55 73 (Pubitemid 46062405)
Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: The effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5′-GMP and DNA
DOI 10.1016/j.jinorgbio.2004.08.011, PII S0162013404002296
S. Moradell, J. Lorenzo, A. Rovira, S. van Zutphen, F.X. Aviles, V. Moreno, R. de Llorens, M.A. Martinez, J. Reedijk, and A. Llobet Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5′-GMP and DNA J. Inorg. Biochem. 98 2004 1933 1946 (Pubitemid 39452695)
Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: Synthesis and comparison with carboplatin in normal and Pt-resistant cell lines
J.F. Arambula, J.L. Sessler, M.E. Fountain, W.H. Wei, D. Magda, and Z.H. Siddik Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines Dalton Trans. 2009 10834 10840
Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity
P. Starha, Z. Travnicek, and I. Popa Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity J. Inorg. Biochem. 104 2010 639 647
Cytotoxic, antioxidant activities and structure activity relationship of some newly synthesized terpenoidal oxaliplatin analogs
G. Amr Ael, K.A. Ali, and M.M. Abdalla Cytotoxic, antioxidant activities and structure activity relationship of some newly synthesized terpenoidal oxaliplatin analogs Eur. J. Med. Chem. 44 2009 901 907
Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment
I. Ott, and R. Gust Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment Anticancer Agents Med. Chem. 7 2007 95 110 (Pubitemid 46062407)
Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor α and β
C. Descoteaux, V. Leblanc, G. Belanger, S. Parent, E. Asselin, and G. Berube Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor α and β Steroids 73 2008 1077 1089
Synthesis of 17β-estradiol platinum(II) complexes: Biological evaluation on breast cancer cell lines
DOI 10.1016/j.bmcl.2003.09.011
C. Descoteaux, J. Provencher-Mandeville, I. Mathieu, V. Perron, S.K. Mandal, E. Asselin, and G. Berube Synthesis of 17β-estradiol platinum(II) complexes: biological evaluation on breast cancer cell lines Bioorg. Med. Chem. Lett. 13 2003 3927 3931 (Pubitemid 37338421)
Design, synthesis and biological evaluation of estradiol-PEG-linked platinum(II) hybrid molecules: Comparative molecular modeling study of three distinct families of hybrids
J. Provencher-Mandeville, C. Debnath, S.K. Mandal, V. Leblanc, S. Parent, E. Asselin, and G. Berube Design, synthesis and biological evaluation of estradiol-PEG-linked platinum(II) hybrid molecules: comparative molecular modeling study of three distinct families of hybrids Steroids 76 2011 94 103
Synthesis of 17β-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines
DOI 10.1016/j.bmcl.2008.03.005, PII S0960894X08002679
J. Provencher-Mandeville, C. Descoteaux, S.K. Mandal, V. Leblanc, E. Asselin, and G. Berube Synthesis of 17β-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines Bioorg. Med. Chem. Lett. 18 2008 2282 2287 (Pubitemid 351442908)
Synthesis of 17 α-substituted ethynylestradiols: Potential ligands for drug vectors
A.R. Yaya, M. Touaibia, G. Massarweh, F.D. Rochon, and L. Breau Synthesis of 17 α-substituted ethynylestradiols: potential ligands for drug vectors Steroids 75 2010 489 498
Transfer RNA bindings to antitumor estradiol-platinum(II) hybrid and cisplatin
DOI 10.1089/dna.2008.0727
C.N. N'Soukpoe-Kossi, C. Descoteaux, E. Asselin, J. Bariyanga, H.A. Tajmir-Riahi, and G. Berube Transfer RNA bindings to antitumor estradiol-platinum(II) hybrid and cisplatin DNA Cell Biol. 27 2008 337 343 (Pubitemid 351843406)
DNA interaction with novel antitumor estradiol-platinum(II) hybrid molecule: A comparative study with cisplatin drug
DOI 10.1089/dna.2007.0669
C.N. N'Soukpoe-Kossi, C. Descoteaux, E. Asselin, H.A. Tajmir-Riahi, and G. Berube DNA interaction with novel antitumor estradiol-platinum(II) hybrid molecule: a comparative study with cisplatin drug DNA Cell Biol. 27 2008 101 107 (Pubitemid 351278373)
Study of DNA interactions with steroidal and nonsteroidal estrogen-platinum (II)-based anticancer drugs
E. Froehlich, A. Gupta, J. Provencher-Mandeville, E. Asselin, J. Bariyanga, G. Berube, and H.A. Tajmir-Riahi Study of DNA interactions with steroidal and nonsteroidal estrogen-platinum (II)-based anticancer drugs DNA Cell Biol. 28 2009 31 39
VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo
C. Van Themsche, S. Parent, V. Leblanc, C. Descoteaux, A.M. Simard, G. Berube, and E. Asselin VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo Endocr. Relat. Cancer 16 2009 1185 1195
Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna, and J.B. Mitchell Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res. 47 1987 936 942 (Pubitemid 17027905)
